Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) Study

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 6, 2010, Pages 471-477

  Haselkorn, Tmirah ^a   Chen, Hubert ^b   Miller, Dave P ^c   Fish, James E ^a   Peters, Stephen P ^d   Weiss, Scott T ^e   Jones, Craig A ^f  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ICON CLINICAL RESEARCH   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f VERMONT DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; CHRONIC SINUSITIS; COMORBIDITY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; ENVIRONMENTAL FACTOR; FEMALE; GASTROESOPHAGEAL REFLUX; HAY FEVER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT MOBILITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; URTICARIA;

ADOLESCENT; ADULT; AGED; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 77953147830     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.04.006     Document Type: Article

References (37)

1. Accordini S., Bugiani M., Arossa W., et al. Poor control increases the economic cost of asthma: a multicentre population-based study. Int Arch Allergy Immunol 141 (2006) 189-198
2. Antonicelli L., Bucca C., Neri M., et al. Asthma severity and medical resource utilisation. Eur Respir J 23 (2004) 723-729
3. Breekveldt-Postma N.S., Erkens J.A., Aalbers R., van de Ven M.J.T., Lammers J.W.J., and Herings R.M.C. Extent of uncontrolled disease and associated medical costs in severe asthma: a PHARMO study. Curr Med Res Opin 24 (2008) 975-983
4. Zeiger R.S., Hay J.W., Contreras R., et al. Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol 121 (2008) 885-892
5. Moore W.C., Bleecker E.R., Curran-Everett D., et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119 (2007) 405-413
6. Sullivan S.D., Rasouliyan L., Russo P.A., Kamath T., Chipps B.E., and TENOR Study Group. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy 62 (2007) 126-133
7. Williams S.A., Wagner S., Kannan H., and Bolge S.C. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med 51 (2009) 780-785
8. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007), National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
9. Adams R.J., Fuhlbrigge A., Guilbert T., Lozano P., and Martinez F. Inadequate use of asthma medication in the United States: results of the Asthma in America National Population Survey. J Allergy Clin Immunol 10 (2002) 58-64
10. Lai C.K., De Guia T.S., Kim Y.Y., et al. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 111 (2003) 263-268
11. Peters S.P., Jones C.A., Haselkorn T., Mink D.R., Valacer D.J., and Weiss S.T. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119 (2007) 1454-1461
12. Rabe K.F., Vermeire P.A., Soriano J.B., and Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
13. Juniper E.F., Buist A.S., Cox F.M., Ferrie P.J., and King D.R. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 115 (1999) 1265-1270
14. Dockrell M., Partridge M.R., and Valovirta E. The limitations of severe asthma: the results of a European survey. Allergy 62 (2007) 134-141
15. Greenfield Online Inc. Form 10-K Annual Report (April 21, 2008), Greenfield Online Inc, Wilton, CT
16. Haselkorn T., Jones C.A., Chen H., et al. Relationship between asthma control and activity limitation: insights from the REACT Study. J Allergy Clin Immunol 121 (2007) S160
17. Nathan R.A., Sorkness C.A., Kosinski M., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
18. Reilly M.C., Zbrozek A.S., and Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4 (1993) 353-365
19. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., and King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999) 902-907
20. Vollmer W.M., Markson L.E., O'Connor E., et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 160 (1999) 1647-1652
21. Adams R.J., Wilson D.H., Taylor A.W., et al. Psychological factors and asthma quality of life: a population based study. Thorax 59 (2004) 930-935
22. Afari N., Schmaling K.B., Barnhart S., and Buchwald D. Psychiatric comorbidity and functional status in adult patients with asthma. J Clin Psychol Med Settings 8 (2001) 245-252
23. Scott K.M., Von Korff M., Ormel J., et al. Mental disorders among adults with asthma: results from the World Mental Health Survey. Gen Hosp Psychiatry 29 (2007) 123-133
24. Mancuso C.A., Peterson M.G., and Charlson M.E. Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med 15 (2000) 301-310
25. Baiardini I., Braido F., Brandi S., and Canonica G.W. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol 97 (2006) 419-428
26. Adams R.J., Wilson D.H., Taylor A.W., et al. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest 129 (2006) 285-291
27. Ben-Noun L. Characteristics of comorbidity in adult asthma. Public Health Rev 29 (2001) 49-61
28. Harding S.M., and Richter J.E. The role of gastroesophageal reflux in chronic cough and asthma. Chest 111 (1997) 1389-1402
29. Senior B.A., and Kennedy D.W. Management of sinusitis in the asthmatic patient. Ann Allergy Asthma Immunol 77 (1996) 15-19
30. ten Brinke A., Grootendorst D.C., Schmidt J.T., et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109 (2002) 621-626
31. Mastronarde J.G., Anthonisen N.R., Castro M., et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360 (2009) 1487-1499
32. Fuhlbrigge A.L., Adams R.J., Guilbert T.W., et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program Guidelines. Am J Respir Crit Care Med 166 (2002) 1044-1049
33. Leidy N.K., and Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 7 (1998) 127-134
34. Osborne M.L., Vollmer W.M., Linton K.L., and Buist A.S. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med 157 (1998) 123-128
35. Apter A.J., Reisine S.T., Affleck G., Barrows E., and Zuwallack R.L. The influence of demographic and socioeconomic factors on health-related quality of life in asthma. J Allergy Clin Immunol 103 (1999) 72-78
36. Eisner M.D., Katz P.P., Yelin E.H., Shiboski S.C., and Blanc P.D. Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res 2 (2001) 53-60
37. Internet users (per 100 people). World Bank Web site. http://datafinder.worldbank.org/internet-users Accessed March 12, 2010